|
Mar 12
|
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
|
Mar 5
|
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
|
|
Feb 28
|
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
|
|
Jan 15
|
Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?
|
|
Dec 5
|
With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing
|
|
Oct 4
|
Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
|
|
Jul 16
|
TipRanks’ ‘Perfect 10’ List: These Monster Growth Stocks Could Reach New Highs
|